Literature DB >> 20632913

Virilising Sertoli-Leydig cell tumour associated with thyroid papillary carcinoma: case report and general considerations.

Catalina Poiana1, Ioana Virtej, Mara Carsote, Gabriel Banceanu, Maria Sajin, Bogdan Stanescu, Dumitru Ioachim, Dan Hortopan, Mihail Coculescu.   

Abstract

We present a case of a Sertoli-Leydig cell tumour manifested with progressive hirsutism, frontal alopecia and secondary amenorrhea in a 46-years-old female, evolving for 6 years until presentation. Serum testosterone level was 8.01 ng/ml and gonadotropic hormones were LH 8.57 mIU/ml and FSH 9.52 mIU/ml. Computed tomography revealed a dense, solid, heterogeneous mass of 3.5/2.8 cm in the right ovary. Bilateral ovariectomy and hysterectomy were performed. The histopathological report mentioned a Sertoli-Leydig cell tumor with intermediate grade of differentiation. Immunohistochemical stains showed positive reaction for alpha-inhibin, calretin and for progesterone receptor. The testosterone levels dramatically decreased after surgery (0.31 ng/ml) while levels of gonadotropes increased: LH 40.98 mIU/ml and FSH 50.41 mIU/ml. At 6 months follow-up the diagnosis of a left lobe thyroid nodule leaded to fine needle aspiration biopsy with suspicion of papillary carcinoma. Total thyroidectomy established the diagnosis of thyroid papillary carcinoma (2.17/2.18 cm) T2N0M0, stage II, followed by radioiodine administration. This is to our knowledge the first presented case of ovarian Sertoli-Leydig cell tumour associated with papillary thyroid carcinoma. This could suggest a common genetic background.

Entities:  

Mesh:

Year:  2010        PMID: 20632913     DOI: 10.3109/09513591003686361

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

Review 1.  The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.

Authors:  Emeline Durieux; Françoise Descotes; Claire Mauduit; Myriam Decaussin; Serge Guyetant; Mojgan Devouassoux-Shisheboran
Journal:  Virchows Arch       Date:  2016-03-16       Impact factor: 4.064

2.  MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).

Authors:  A A Gheorghisan-Galateanu; D Terzea; A Valea; M Carsote
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

3.  Analyzing the Role of DICER1 Germline Variations in Papillary Thyroid Carcinoma.

Authors:  Sule Canberk; Joana C Ferreira; Luísa Pereira; Rui Batısta; Andre F Vieira; Paula Soares; Manuel Sobrinho Simões; Valdemar Máximo
Journal:  Eur Thyroid J       Date:  2020-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.